HCA Holdings Inc. buy Royal Bank of Canada
Start price
25.10.23
/
50%
€213.30
Target price
25.10.24
€268.66
Performance (%)
41.61%
Price
29.05.24
€300.90
Summary
This prediction is currently active. With a performance of 41.61% the BUY prediction by Royal_Bank_of_Canada is a big success. A total of €1.16 was paid as dividends for this prediction. This prediction currently runs until 25.10.24. The prediction end date can be changed by Royal_Bank_of_Canada at any time. Royal_Bank_of_Canada has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
HCA Holdings Inc. | 1.347% | 1.347% |
iShares Core DAX® | -0.683% | 1.890% |
iShares Nasdaq 100 | 0.335% | 4.631% |
iShares Nikkei 225® | -1.486% | -2.361% |
iShares S&P 500 | -0.523% | 2.324% |
Comments by Royal_Bank_of_Canada for this prediction
In the thread HCA Holdings Inc. diskutieren
HCA Healthcare, Inc. (NYSE: HCA) had its price target lowered by analysts at Royal Bank of Canada from $315.00 to $284.00. They now have an "outperform" rating on the stock.
Ratings data for HCA provided by MarketBeat
Stopped prediction by Royal_Bank_of_Canada for HCA Holdings Inc.
HCA Holdings Inc.
Start price
Target price
Perf. (%)
€290.50
29.04.24
29.04.24
€307.19
29.04.25
29.04.25
3.58%
29.05.24
29.05.24
HCA Holdings Inc.
Start price
Target price
Perf. (%)
€282.20
31.01.24
31.01.24
€296.76
31.01.25
31.01.25
6.84%
29.05.24
29.05.24
HCA Holdings Inc.
Start price
Target price
Perf. (%)
€244.70
13.09.23
13.09.23
€293.45
13.09.24
13.09.24
23.67%
29.05.24
29.05.24